50th anniversary of the Salk Polio vaccine
On Apr. 12, 2005 marked the 50th anniversary of the announcement that the polio vaccine, developed by Jonas…
-
-
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
-
The first meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Menactra by Sanofi Pasteur) was licensed
On Jan. 14, 2005, the first meningococcal polysaccharide (Serogroups A, C, Y and W-135) diphtheria toxoid conjugate vaccine…
-
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
-
Biotechnology | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
PNNL lands $10.3 million NIH biodefense contract to unlock proteomes of salmonella and pox
On Sept. 14, 2004, Pacific Northwest National Laboratory (PNNL) announced it had received a $10.3 million biodefense contract…
-
A significant shortage of influenza vaccine occurred in the U.S.
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
-
The 8th and final report of the Immunization Safety Review Committee was issued by the Institute of Medicine
On Jun. 26, 2004, the eighth and final report of the Immunization Safety Review Committee examines the hypothesis…
-
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
-
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
-
Biotechnology | NIH | Vaccine
NIAID awarded a new license agreement for RotaShield, an oral rotavirus vaccine
On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…
-
The National incident Management System was established to coordinate response for public health incidents
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
-
Rubella was declared eliminated in the U.S.
In 2004, Rubella, also known as German measles, was declared eliminated in the U.S. Before the rubella vaccination…
-
The University of Georgia Cancer Center was established
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…
-
ACIP voted to recommend influenza vaccination for children aged 6 to 23 months
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
-
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
-
OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreak
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
-
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) announced a total of 71…
-
The first nasally administered influenza vaccine (FluMist by MedImmune) was licensed
On Jun. 17, 2003, the U.S. Food and Drug Administration (FDA) announced it had approved FluMist. This was…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Michael Smith Genome Science Centre sequenced the SARS genome
On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
-
Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list
On Mar. 18, 2003, Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list. Persons under quarantine…
-
Biotechnology | HIV | Therapeutics | Vaccine
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
-
Biotechnology | CDC | Disease | HIV | NIH | Therapeutics | Vaccine
U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established
On Jan. 26, 2003, President George W. Bush, in his State of the Union Address, announced the Emergency…
-
Public health officials were concerned about re-emergence of H5N1 avian influenza
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
-
FDA | Infectious Disease | Polio | Vaccine
Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed
On Dec. 13, 2002, the U.S. Food and Drug Administration (FDA) announced it had licensed a combined diphtheria…
-
President Bush announced a major smallpox vaccination program
On Dec. 13, 2002, President Bush announced a major smallpox vaccination program to protect the nation against the…
-
NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune response
On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…
-
Diagnostics | Infectious Disease | Polio | Vaccine | WHO
The European Region was certified polio-free
On Jun. 21, 2002, all 53 Member States in the World Health Organization (WHO) European Region were certified…
-
Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
-
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
-
Rotary International launched a second fundraising campaign to eradicate polio
In 2002, the Rotary International launched a Polio Eradication Fundraising Campaign with a fundraising target of $80 million…
